Press Releases

Predictmedix Unveils Revolutionary Fitness Scan Vertical for Athletes, Teams, and Sports Federations

May 17, 2023 - Press Releases

Toronto, Ontario – May 17, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), is proud to announce the launch of its ground-breaking fitness scan vertical tailored specifically for athletes, teams, and sports federations. Leveraging state-of-the-art AI […]

Predictmedix Launches AI-Driven Comprehensive Triage Solution with Expanded Vital Parameter Measurements for High Traffic Hospitals in Targeted Asian Region

May 10, 2023 - Press Releases

Toronto, Ontario – May 10, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), is proud to announce the launch of its ground-breaking complete triage solution. Predictmedix’s cutting-edge system encompasses a wide range of parameters, including 8 […]

Predictmedix Introduces Ground-breaking Technology for Cardiovascular Risk Management: Safe Entry Stations Now Measure Blood Pressure, Heart Rate Variability and Blood Oxygen Non-Invasively

Apr 19, 2023 - Press Releases

Toronto, Ontario – April 19, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), is proud to announce a significant advancement in its Safe Entry Stations. The Company’s AI-powered screening technology will now be able to take […]

Predictmedix Receives Purchase Order Valued at $500k from MGM Healthcare for AI-Powered Safe Entry Stations to Enhance Healthcare Operations

Mar 30, 2023 - Press Releases

Toronto, Ontario – March 30, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), today announced a purchase order from one of the largest Government hospital groups in India, MGM Healthcare, for the company’s AI-powered Safe Entry […]

Predictmedix’s Safe Entry Receives International Recognition in Major Indonesian Newspaper for its Healthcare Application

Mar 28, 2023 - Press Releases

Toronto, Ontario – March 28, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), is thrilled to announce that it’s AI-powered technology, powering the Safe Entry Station, was Featured in a major Indonesian newspaper published on March […]

Predictmedix Expands on Non-Invasive AI-powered Impairment Detection Technology for Vertical-Specific Applications

Mar 23, 2023 - Press Releases

Toronto, Ontario – March 23, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI) is excited to announce an update on the functionality and application of their technology across specific verticals. The update comes after the Company’s […]

Predictmedix Announces US Patent Grant for AI-Powered Impairment Detection Technology for Cannabis and Alcohol Screening

Mar 21, 2023 - Press Releases

  Toronto, Ontario – March 20, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI), announced today that the US Patent Office has granted a patent for its AI-powered technology (United States Patent Application Number: 16/892,369) for […]

Predictmedix Announces Production of AI-Powered Mobile Application to Rapidly Detect Impairment from Alcohol and Cannabis

Mar 15, 2023 - Press Releases

  Predictmedix has begun production of its mobile application for detecting impairment from cannabis and alcohol Predictmedix’s screening to identify impairment takes less than 30 seconds The mobile application, powered by AI algorithms currently being utilized in Safe Entry will be accompanied by a “mini” multi-spectral imaging camera resulting in a portable non-invasive impairment detection […]

Predictmedix Announces Completion of 1600-Person Clinical Study for Safe Entry’s Medical Device Regulatory Approval in Indonesia

Mar 8, 2023 - Press Releases

The 1600-person study at a prestigious University in Jakarta, Indonesia prepares Predictmedix’s Safe Entry for regulatory approval listed as a ‘Medical Device’   Medical device classification allows Predictmedix to commercialize Safe Entry at scale in Indonesia   Third-party clinical validation yet another milestone for Predictmedix’s AI-Powered screening technology   Toronto, Ontario, March 8, 2023 – […]

Predictmedix Announces a Purchase Order for Safe Entry’s Fit for Duty Screening in the Defence Sector

Mar 6, 2023 - Press Releases

DefSpace, a global platform for Defence, Space and Aerospace will lease four Safe Entry Stations over four-year term primarily utilizing Safe Entry’s impairment detection screening   Each of the four Safe Entry Station’s to generate $2500 per month in recurring revenue for an initial four-year term, approximating a total of $500,000   The Global workplace […]

Predictmedix Announces Third-Party Independent Clinical Validation for AI-Powered Screening following 400 Patient Study at MGM Healthcare

Feb 15, 2023 - Press Releases

Toronto, Ontario, February 15, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced pivotal clinical validation data from one of the largest Government hospital groups in India for the company’s AI-powered Safe Entry Stations. […]

Predictmedix Closes $612,500 Private Placement and Announces Listing on the Frankfurt Exchange

Feb 13, 2023 - Press Releases

Toronto, Ontario, February 13, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announces that it has closed a non-brokered private placement for total gross proceeds of $612,500. The Company has issued 12,250,000 units (the “Units”) […]